- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Nasdaq
Wall Street JournalEN
N
NCNA
Nucana
2.10
-0.04-2.10%After Hours: 2.150 +0.050 +2.38%18:38 02/20 EST
OPEN/PREV CLOSE2.140/2.145
TODAY RANGE2.090-2.200
VOL19.15K
MARKET CAP15.06M
52 WEEK RANGE2.000-268.00
AVG VOL (3M)66.70K
% TURNOVER0.27%
TURNOVER--
P/E (TTM)-0.0003
% RANGE4.66%
EPS(TTM)-7,107.9590
P/E(FORWARD)-0.2019
P/B0.4319
BVPS4.863
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP15.06M
SHARES OUTSTANDING7.17M
NEXT EARNINGS03/18-03/23
FREE FLOAT7.17M
LOT SIZE1
EX-DATE08/11/2025
News
Press Releases
Financial Reports
Profile
Benzinga·02/03 21:05
12 Health Care Stocks Moving In Tuesday's After-Market Session
Seeking Alpha·01/06 14:08
NuCana appoints Theresa Bruce as chief operating officer
TipRanks·01/06 13:27
NuCana Names Theresa Bruce Chief Operating Officer to Drive Oncology Pipeline
Benzinga·01/06 13:01
NuCana Appoints Theresa Bruce COO, Effective Jan. 1
Reuters·01/06 13:00
NuCana Appoints Theresa Bruce as Chief Operating Officer
Reuters·12/17/2025 14:18
BRIEF-NuCana Reinstates Hugh Griffith as CEO and Chief Executive Officer
TipRanks·12/17/2025 13:27
NuCana Announces Return of CEO Hugh S. Griffith Following Health Leave
Benzinga·12/17/2025 13:15
Nucana Reappoints Hugh S. Griffith As CEO, Effective Dec. 15
Reuters·12/17/2025 13:12
Hugh S. Griffith Returns as NuCana CEO
TipRanks·12/10/2025 13:47
NuCana Showcases Promising Results for NUC-7738 in Melanoma Treatment
TipRanks·12/10/2025 13:15
NuCana presents latest clinical data at ESMO 2025 on NUC-7738
TipRanks·12/10/2025 13:05
NuCana presents data at ESMO on NUC-7738
Reuters·12/10/2025 13:00
NuCana Reports Positive Phase 2 Results for NUC-7738 in PD-1-Resistant Melanoma
Benzinga·11/20/2025 21:06
12 Health Care Stocks Moving In Thursday's After-Market Session
TipRanks·11/13/2025 22:12
NuCana Reports Q3 2025 Financial Results and Board Resignation
Same Industry
Name/Symbol
Change%
Price